Effect of Anti-oxidant Treatment on Hyperhomocysteinemia-induced Myocardial Fibrosis and Diastolic Dysfunction

Journal of Heart and Lung Transplantation

Volumn 27, Issue 11, 2008, Pages 1237-1241

  Joseph, Jacob ^a,b   Joseph, Lija ^b   Devi, Sulochana ^b   Kennedy, Richard H ^c  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIASTOLE; DIASTOLIC DYSFUNCTION; DIET THERAPY; HEART MUSCLE FIBROSIS; HYPERHOMOCYSTEINEMIA; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SYSTOLE;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BODY WEIGHT; COLLAGEN; CORONARY VESSELS; DIASTOLE; ENDOMYOCARDIAL FIBROSIS; HEART; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN E;

EID: 54249099902     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.07.024     Document Type: Article

References (13)

1. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., and Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006) 251-259
2. Joseph J., Washington A., Joseph L., et al. Hyperhomocysteinemia leads to Am J Physiol Heart Circ Physiol 283 (2002) H2567-H2574
3. Joseph J., Joseph L., Shekhawat N., et al. Hyperhomocysteinemia leads to pathologic ventricular hypertrophy in normotensive rats. Am J Physiol Heart Circ Physiol 285 (2003) H679-H686
4. Vasan R.S., Beiser A., D'Agostino R.B., et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA 289 (2003) 1251-1257
5. Bonaa K.H., Njolstad I., Ueland P.M., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354 (2006) 1578-1588
6. Loscalzo J. The oxidant stress of hyperhomocysteinemia. J Clin Invest 98 (1996) 5-7
7. Devi S., Kennedy R.H., Joseph L., Shekhawat N.S., and Joseph J. Effect of long-term hyperhomocysteinemia on myocardial structure and function in hypertensive rats. Cardiovasc Pathol 15 (2006) 75-82
8. Sood H.S., Cox M.J., and Tyagi S.C. Generation of nitrotyrosine precedes activation of metalloproteinase in myocardium of hyperhomocysteinemic rats. Antioxid Redox Signal 4 (2002) 799-804
9. Kennedy R.H., Melchert R.B., and Joseph J. Cardiovascular effects of hyperhomocysteinemia in conscious unrestrained rats. Am J Hyperten 19 (2006) 94-97
10. Pfeffer M.A., Pfeffer J.M., Dunn F.G., Nishiyama K., Tsuchiya M., and Frohlich E.D. Natural biventricular hypertrophy in normotensive rats. I. Physical and hemodynamic characteristics. Am J Physiol 236 (1979) H640-H643
11. Aiello E.A., Villa-Abrille M.C., Escudero E.M., et al. Myocardial hypertrophy of the normotensive WKY rats. Am J Physiol Heart Circ Physiol 286 (2004) H1229-H1235
12. Behrendt D., Beltrame J., Hikiti H., et al. Impact of coronary endothelial function on the progression of cardiac transplant-associated arteriosclerosis: effect of anti-oxidant vitamins C and E. J Heart Lung Transplant 25 (2006) 426-433
13. Joseph J., Kennedy R.H., Joseph L., Devi S., Wang J., and Hauer-Jensen M. Protective Role of Mast Cells in Hyperhomocysteinemia-induced Cardiac Remodeling. Am J Physiol Heart Circ Physiol 288 (2005) 2541-2545